The UltraMind Solution (143 page)

6
. Anisman, H., and Z. Merali. 2003. Cytokines, stress and depressive illness: Brain-immune interactions.
Ann Med
35:2–11.

7
. Banks, W. A., S. A. Farr, and J. E. Morley. 2002–2003. Entry of blood-borne cytokines into the central nervous system: Effects on cognitive processes.
Neuroimmunomodulation
10:319–27.

8
. Rivier, C. 1993. Effect of peripheral and central cytokines on the hypothalamic-pituitary-adrenal axis in the rat.
Ann N Y Acad Sci
697:97–105.

9
. Carlson, S. L., et al. 1987. Alternations of monoamines in specific central autonomic nuclei following immunization in mice.
Brain Behav Immun
1:52–63.

10
. Shattock, P., and P. Whiteley. 2002. Biochemical aspects in autism spectrum disorders: Updating the opioid-excess theory and presenting new opportunities for biomedical intervention.
Expert Opin Ther Targets
6 (2):175–83. Review.

11
. Pimentel, M., et al. 2006. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: A randomized trial.
Ann Intern Med
145 (8):557–63.

12
. Av, S. P. 2007. Hepatic encephalopathy: Pathophysiology and advances in therapy.
Trop Gastroenterol
28 (1):4–10. Review.

13
. Jansson-Nettelbladt, E., et al. 2006. Endogenous ethanol fermentation in a child with short bowel syndrome.
Acta Paediatr
95 (4):502–4.

14
. Kidd, P. M. 2002. Autism, an extreme challenge to integrative medicine. Part 2: Medical management.
Altern Med Rev
7 (6):472–99. Review.

15
. Sandler, R. H., et al. 2000. Short-term benefit from oral vancomycin treatment of regressive-onset autism.
J Child Neurol
15 (7):429–35.

16
. Parracho, H. M., et al. 2005. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children.
J Med Microbiol.
54 (Pt. 10):987–91.

17
. Walsh, W. J., L. B. Glab, and M. L. Haakenson. 2004. Reduced violent behavior following biochemical therapy.
Physiol Behav
82 (5):835–39.

18
. Ibid.

19
. Benton, D. 2001. The impact of diet on antisocial, violent and criminal behaviour.
Neurosci Biobehav Rev
31 (5):752–74. Epub 2007 March 4. Review.

20
. Wakefield, A. J., et al. 2002. Review article: The concept of entero-colonic encephalopathy, autism and opioid receptor ligands.
Aliment Pharmacol Ther
16 (4):663–74.

21
. Aytac, U., and N. H. Dang. 2004. CD26/dipeptidyl peptidase IV: A regulator of immune function and a potential molecular target for therapy.
Curr Drug Targets Immune Endocr Metabol Disord
4 (1):11–8. Review.

22
. Mentlein, R. 1999. Dipeptidyl-peptidase IV (CD26)—role in the inactivation of regulatory peptides.
Regul Pept
85 (1):9–24. Review.

23
. Shattock, P., and P. Whiteley. 2002. Biochemical aspects in autism spectrum disorders: Updating the opioid-excess theory and presenting new opportunities for biomedical intervention.
Expert Opin Ther Targets
6 (2):175–83.

24
. Ek, J., M. Stensrud, and K. L. Reichelt. 1999. Gluten-free diet decreases urinary peptide levels in children with celiac disease.
J Pediatr Gastroenterol Nutr
29 (3):282–85.

25
. Liu, Y., T. Heiberg, and K. L. Reichelt. 2007. Towards a possible aetiology for depressions?
Behav Brain Funct
14 3:47.

26
. Wakefield, A. I., et al. 2005. The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder.
Eur J Gastroenterol Hepatol
17 (8):827–36.

27
. Uhlmann, V., et al. 2002. Potential viral pathogenic mechanism for new variant inflammatory bowel disease.
Mol Pathol
55 (2):84–90.

28
. Kawashima, H., et al. 2002. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism.
Dig Dis Sci
45 (4):723–29.

29
. Bradstreet, J. J., et al. 2004. Detection of measles virus genomic RNA in cerebrospinal fluid of children with regressive autism: A report of three cases.
J. Am Phys Surgeons
38–45.

30
. Taylor, B., et al. 1999. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.
Lancet
353 (9169):2026–2029.

31
. Millward, C., et al. 2004. Gluten-and casein-free diets for autistic spectrum disorder.
Cochrane Database Syst Rev
(2):CD003498. Review.

32
. Hu, W. T., et al. 2006. Cognitive impairment and celiac disease.
Arch Neurol
63 (10):1440–446.

33
. Kalaydijian, A. E., et al. 2006. The gluten connection: The association between schizophrenia and celiac disease.
Acta Psychiatr Scand
113 (2):82–90. Review.

34
.
www.gut.bmjjournals.com/cgi/content/abstract/53/10/1459
(Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial).

35
. Shaheen, N., and F. Ransohoff. 2002. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: Scientific Review.
JAMA
287: 1972–1981.

36
.
www.en.wikipedia.org/wiki/List_of_top_selling_drugs

37
. Ruscin, J. M., R. L. Page, and R. J. Valuck. 2002. Vitamin B
12
deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor.
Ann Pharmacother
36 (5):812–16.

38
. Dial, S., et al. 2005. Use of gastric acid-suppressive agents and the risk of community acquired
Clostrium difficile
-Associated Disease.
JAMA
294 (23):2989–2995.

Chapter 10: Key #5: Enhance Detoxification

1
.
www.cdc.gov/nchs/fastats/lcod.htm
.

2
. Plassman, H. I., et al. 2008. Prevalence of cognitive impairment without dementia in the United States.
Ann Intern Med
148 (6):427–34.

3
. Tsai, M. S., et al. 1994. Apolipoprotein E: risk factor for Alzheimer disease.
Am J Hum Genet
. 54 (4):643–49.

4
. Godfrey, M. E., D. P. Wojcik, and C. A. Krone. 2003. Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity.
J Alzheimer’s Dis
5 (3):189–95.

5
. Clarkson, T.W., L. Magos, and G. Myers. 2003. The toxicology of mercury—current exposures and clinical manifestations.
N Engl J Med
349 (18):1731–1737. Review.

6
. Wojcik, D. P., et al. 2006. Mercury toxicity presenting as chronic fatigue, memory impairment and depression: diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994–2006).
Neuro Endocrinol Lett
27 (4):415–23.

7
. Stroombergen, M. C., and R. H. Waring. 1999. Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease.
Hum Exp Toxicol
18 (3):141–45.

8
. Bernardini, S., et al. 2005. Glutathione S transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: Association study and relationship with apolipoprotein E epsilon4 allele.
Clin Chem
51 (6):944–51. Epub 2005 April 1.

9
. Spalletta, G., et al. 2007. Glutathione S-transferase P1 and T1 gene polymorphisms predict longitudinal course and age at onset of Alzheimer disease.
Am J Geriatr Psychiatry
15 (10):879–87.

10
. Gundacker, C., et al. 2007. Glutathione-S-transferase polymorphism, metallothionein expression, and mercury levels among students in Austria.
Sci Total Environ
385 (1–3):37–47. Epub 2007 Aug 22.

11
. Dorszewska, J., et al. 2007. Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR, MTHFD1 in Alzheimer’s and Parkinson’s diseases.
Acta Neurobiol Exp
(Wars) 67 (2):113–29.

12
. Rodríguez, E., et al. 2006. Cholesteryl ester transfer protein (CETP) polymorphism
modifies the Alzheimer’s disease risk associated with APOE epsilon4 allele.
J Neurol
253 (2):181–85. Epub 2005 Aug 17.

13
. Mutter, J., et al. 2007. Mercury and Alzheimer’s disease.
Fortschr Neurol Psychiatr
75 (9):528–38.

14
. Torres-Alanis, O., et al., 2000. Urinary excretion of trace elements in humans after sodium 2, 3-dimercaptopropane-1-sulfonate challenge test.
J Toxicol Clin Toxicol
38 (7):697–700.

15
. www.iaomt.org/articles/category_view.asp?intReleaseID=271&catid=30

16
. Huse, D. M., et al. 2005. Burden of illness in Parkinson’s disease.
Mov Disord
20 (11):1449–1454.

17
. Tanner, C. M., et al. 1999. Parkinson disease in twins: An etiologic study.
JAMA
281 (4):341.

18
. Cummings, J. L. 2007. Understanding Parkinson Disease.
JAMA
(1999) 281:376–78.

19
. Ayala, A., et al. Mitochondrial toxins and neurodegenerative diseases.
Front Biosci
(12):986–1007. Review.

20
. Kobal Grum, D., et al. 2006. Personality traits in miners with past occupational elemental mercury exposure.
Environ Health Perspect
114 (2):290–96.

21
. Elbaz, A., C. Dufouil and A. Alpérovitch. 2007. Interaction between genes and environment in neurodegenerative diseases.
C. R. Biol
330 (4):318–28. Epub 2007 Apr 9. Review.

22
. Skaper, S. D. 2007. The brain as a target for inflammatory processes and neuroprotective strategies.
Ann N Y Acad Sci
1122:23–34.

23
. Cummings, J. L. 1999. Understanding Parkinson’s disease.
JAMA
281 (4):376–78.

24
. Schapira, A. H., and C. W. Olanow. 2004. Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions.
JAMA
291 (3):358–64. Review.

25
. Berg, D. 2006. Marker for a preclinical diagnosis of Parkinson’s disease as a basis for neuroprotection.
J Neural Transm Suppl
(71):123–32.

26
. Menke, A., et al. 2006. Blood level below 0.48 micromal/L (10 microg/dL) and mortality among U.S. adults.
Circulation
114 (13):1388–1394.

27
. Lindh, U., et al. 2002. Removal of dental amalgam and other metal alloys supported by antioxidant therapy alleviates symptoms and improves quality of life in patients with amalgam-associated ill health.
Neuro Endocrinol Lett
23 (5–6):459–82.

28
. Zachi, E. C., M.A. Faria and A. Taub. 2007. Neuropsychological dysfunction related to earlier occupational exposure to mercury vapor.
Braz J Med Biol Res
Mar 40 (3):425–33.

29
. Kokayi, K., et al. 2006. Findings of and treatment for high levels of mercury and lead toxicity in ground zero rescue and recovery workers and lower Manhattan residents.
Explore
(NY) 2 (5):400–7.

30
. Ritvo, E. R., et al. 1986. Retinal pathology in autistic children—a possible biological marker for a subtype?
J Am Acad Child Psychiatry
25 (1):137.

31
. Megson, M. N. 2000. Is autism a G-alpha protein defect reversible with natural vitamin A?
Med Hypotheses
54 (6):979–83.

32
. Peixoto, N. C., et al. 2007. Metallothionein, zinc, and mercury levels in tissues of young rats exposed to zinc and subsequently to mercury.
Life Sci
81 (16):1264– 1271. Epub 2007 September 16.

33
.
http://www.autism.com/triggers/vaccine/heavymetals.pdf

34
. Holmes, A. S., M. F. Blaxill and B. E. Haley. 2003. Reduced levels of mercury in first baby haircuts of autistic children.
Int J Toxicol
22 (4):277–85.

35
. Adams, J. B., et al. 2007. Mercury, lead, and zinc in baby teeth of children with autism versus controls.
J Toxicol Environ Health A
70 (12):1046–1051.

Other books

Love Finds a Way by Wanda E. Brunstetter
Slob by Ellen Potter
Criminally Insane by Conrad Jones
Tristan's Redemption by Blackburn, Candace
Time for Love by Kaye, Emma
Midnight on the Moon by Mary Pope Osborne
Rio Loco by Robert J. Conley
Her Accidental Angel by Melisse Aires